S-1090 is an orally-active cephalosporin under development by Shionogi, currently in phase III clinical trials [269191]. It has broad-spectrum activity (excluding Pseudomonas aeruginosa (P aeruginosa), Serratia marcescens (S marcescens) and Proteus vulgaris (P vulgaris)), a long half-life of about 3 h, and high serum protein binding of greater than 95% [221654], [166465]. Phase I pharmacokinetic trials of S-1090 in comparison to other oral cephalosporins, including cefdinir, showed the compound to have favorable characteristics. It had a higher plasma Cmax, longer half-life, and a larger AUC in healthy volunteers. Food intake increased the absorption and excretion of S-1090 after oral administration [187813].

Mazzaglia, G. (1999). S-1090 Shionogi. CURRENT OPINION IN ANTI-INFECTIVE INVESTIGATIONAL DRUGS, 1(1), 57-63.

S-1090 Shionogi

Mazzaglia G
1999

Abstract

S-1090 is an orally-active cephalosporin under development by Shionogi, currently in phase III clinical trials [269191]. It has broad-spectrum activity (excluding Pseudomonas aeruginosa (P aeruginosa), Serratia marcescens (S marcescens) and Proteus vulgaris (P vulgaris)), a long half-life of about 3 h, and high serum protein binding of greater than 95% [221654], [166465]. Phase I pharmacokinetic trials of S-1090 in comparison to other oral cephalosporins, including cefdinir, showed the compound to have favorable characteristics. It had a higher plasma Cmax, longer half-life, and a larger AUC in healthy volunteers. Food intake increased the absorption and excretion of S-1090 after oral administration [187813].
Articolo in rivista - Articolo scientifico
Scientifica
cephalosporins; phase III clinical trials; metabolism; Side-effects and Contraindications
English
Mazzaglia, G. (1999). S-1090 Shionogi. CURRENT OPINION IN ANTI-INFECTIVE INVESTIGATIONAL DRUGS, 1(1), 57-63.
Mazzaglia, G
File in questo prodotto:
File Dimensione Formato  
1999 Curr Opinion.pdf

Solo gestori archivio

Dimensione 103.28 kB
Formato Adobe PDF
103.28 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/225137
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact